AFYA Stock Recent News

Investors need to pay close attention to AFYA stock based on the movements in the options market lately.

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that it will host its Afya Day on October 29th, 2024. The event will be held in a hybrid format, combining both in-person and online participation, and will feature presentations from Afya's executive team, covering the Company's growth, business strategy and future outlook. Event Details: Da.

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced a public commitment to achieve 5 million free health consultations by 2030, in line with Sustainable Development Goal 3 (SDG 3), which aims to ensure healthy lives and promote well-being for all people, at all ages. To serve the communities and achieve the estimated results, Afya intends to increas.

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that following the conclusion of an administrative procedure, the Ministry of Education (“MEC”), has granted the request for reconsideration submitted by Universidade do Grande Rio Professor José de Souza Herdy (“Unigranrio”). Per the e-MEC portal, Unigranrio reestablished 10 medical seats in.

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced today that its wholly-owned subsidiary, Afya Participações S.A., has received the total disbursement of BRL500.0 million under the loan agreement with International Finance Corporation ("IFC") to support the Company's expansion program. The financing is IFC's first sustainability-linked loan based o.

Afya's Q2 2024 results showed stable operations with 14% revenue growth, driven by increased enrollment and tuition, and improved operating margins. A favorable Supreme Court ruling on medical seat openings and new financing from the IFC are positive developments for Afya. Despite short-term stability, long-term concerns arise due to potential oversupply in Brazil's medical education and profession markets.

Afya (AFYA) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.29 per share a year ago.

Afya Limited (NASDAQ:AFYA ) Q2 2024 Earnings Conference Call August 14, 2024 5:00 PM ET Corporate Participants Renata Couto - Investor Relations Virgilio Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Conference Call Participants Mirela Oliveira – Bank of America Lucca Marquezini - Itau Leandro Bastos - Citi Marcelo Santos - JPMorgan Mauricio Cepeda - Morgan Stanley Renata Couto Thank you for joining us for Afya's Conference Call. I'm here today with Afya's CEO, Virgilio Gibbon, and our CFO, Luis Andre Blanco.

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34), the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2023 Sustainability Report. The document, which presents Afya's trajectory throughout 2023, follows the Global Reporting Initiative (GRI) standards and is aligned with the Sustainable Development Goals (SDGs). It also reports specific indicators from the Sustainability Accounting Standards Board (SASB) an.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.